Arthritis & Rheumatic Disease Specialties Research Report issue

Academic/Hospital Phase 2 Phase 3

Organization Overview

First Clinical Trial
2007
NCT00425932
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2015

Timeline

NOW
  • Now

Alternative names

Arthritis & Rheumatic Disease Specialties | Norman B. Gaylis, MD